mifepristone has been researched along with Acute Confusional Senile Dementia in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 7 (58.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, D; Huang, R; Li, W; Wang, Y; Xu, T; Yin, Y; Zhang, B; Zhang, J; Zhang, Y | 1 |
O'Banion, MK | 1 |
Barik, J; Bethus, I; Chafai, M; Kootar, S; Lanté, F; Marie, H; Mouska, X; Pereira, AR; Raymond, EF | 1 |
Belanoff, JK; Canet, G; Chevallier, N; Desrumaux, C; Givalois, L; Hunt, H; Ollivier, M; Pineau, F | 1 |
Ling, D; Salvaterra, PM | 1 |
Chen, L; Fuchs, PM; Kanazirska, MV; Lal, S; Vassilev, PM; Verma, J | 1 |
Baglietto-Vargas, D; Green, KN; LaFerla, FM; Martinez-Coria, H; Medeiros, R | 1 |
Belanoff, J; DeBattista, C | 1 |
Cooper, TB; de la Pena, CB; Ferris, S; Hernando, RT; Pomara, N; Sidtis, JJ | 1 |
Anand, KS; Dhikav, V | 1 |
Lam, FC; Liu, R; Lu, P; Reiner, PB; Renoir, JM; Shapiro, AB; Sharom, FJ | 1 |
Doraiswamy, PM; Ferris, S; Pomara, N; Tun, H | 1 |
1 review(s) available for mifepristone and Acute Confusional Senile Dementia
Article | Year |
---|---|
C-1073 (mifepristone) in the adjunctive treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognition Disorders; Drug Therapy, Combination; Humans; Mifepristone; Receptors, Glucocorticoid | 2005 |
2 trial(s) available for mifepristone and Acute Confusional Senile Dementia
Article | Year |
---|---|
The effect of mifepristone (RU 486) on plasma cortisol in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dexamethasone; Double-Blind Method; Female; Glucocorticoids; Hormone Antagonists; Humans; Hydrocortisone; Male; Middle Aged; Mifepristone; Placebos; Prospective Studies; Receptors, Glucocorticoid | 2006 |
Mifepristone (RU 486) for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Anorexia; Cognition; Double-Blind Method; Drug Eruptions; Fatigue; Female; Headache; Hormone Antagonists; Humans; Hypokalemia; Male; Mifepristone; Neuropsychological Tests; Pilot Projects; Receptors, Glucocorticoid; Treatment Outcome | 2002 |
9 other study(ies) available for mifepristone and Acute Confusional Senile Dementia
Article | Year |
---|---|
Chronic dexamethasone treatment results in hippocampal neurons injury due to activate NLRP1 inflammasome in vitro.
Topics: Adaptor Proteins, Signal Transducing; Alzheimer Disease; Animals; Apoptosis Regulatory Proteins; Cell Death; Cells, Cultured; Dexamethasone; Hippocampus; Humans; Inflammasomes; Long Term Adverse Effects; Mifepristone; Neurogenic Inflammation; Neurons; NF-kappa B; NLR Proteins; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2017 |
It may take more than a shot: alternatives to immunotherapy for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Hormone Antagonists; Humans; Immunotherapy; Male; Mifepristone; tau Proteins | 2013 |
Subchronic glucocorticoid receptor inhibition rescues early episodic memory and synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Dexamethasone; Disease Models, Animal; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glucocorticoids; Hippocampus; Hormone Antagonists; Humans; Memory Disorders; Memory, Episodic; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mifepristone; Mutation; Neuronal Plasticity; Quinoxalines; Receptors, Glucocorticoid; Recognition, Psychology; Valine | 2015 |
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aza Compounds; Cognitive Dysfunction; Disease Models, Animal; Dose-Response Relationship, Drug; Glucocorticoids; Heterocyclic Compounds, 4 or More Rings; Hippocampus; Hypothalamo-Hypophyseal System; Isoquinolines; Male; Mifepristone; Molecular Targeted Therapy; Pituitary-Adrenal System; Pyrazoles; Rats, Sprague-Dawley; Receptors, Glucocorticoid | 2016 |
Brain aging and Aβ₁₋₄₂ neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging.
Topics: Age Factors; Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Autophagy; Brain; Disease Models, Animal; Drosophila; Drosophila Proteins; Gene Expression Regulation; Green Fluorescent Proteins; Hormone Antagonists; Humans; Lysosomes; Microscopy, Confocal; Microscopy, Electron, Transmission; Mifepristone; Neurons; Peptide Fragments | 2011 |
Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Drug Carriers; Endosomes; Humans; Kaempferols; Lactic Acid; Lysosomes; Memantine; Mifepristone; Nanoparticles; Neuroprotective Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Resveratrol; Stilbenes | 2012 |
Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; CREB-Binding Protein; Hormone Antagonists; Male; Maze Learning; Mice; Mice, Transgenic; Mifepristone; tau Proteins | 2013 |
Glucocorticoids may initiate Alzheimer's disease: a potential therapeutic role for mifepristone (RU-486).
Topics: Alzheimer Disease; Glucocorticoids; Humans; Mifepristone; Models, Biological | 2007 |
beta-Amyloid efflux mediated by p-glycoprotein.
Topics: Adenosine Triphosphate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anilino Naphthalenesulfonates; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Cell Line; Cell Membrane; Cricetinae; Humans; Kidney; Mifepristone; Mutation; Peptide Fragments; Secretory Vesicles; Transfection | 2001 |